Evaluation of the Reported Rates of Severe Hypersensitivity Reactions Associated with Ferric Carboxymaltose and Iron (III) Isomaltoside 1000 in Europe Based on Data from EudraVigilance and VigiBase™ between 2014 and 2017.

Evaluation of the Reported Rates of Severe Hypersensitivity Reactions Associated with Ferric Carboxymaltose and Iron (III) Isomaltoside 1000 in Europe Based on Data from EudraVigilance and VigiBase™ between 2014 and 2017. — المؤلف: Ehlken, Birgit — Drug safety 20200124

المؤلف
Ehlken, Birgit
النشر
Drug safety 20200124
الوصف
463-471 p.
الموضوعات
Databases, Factual؛ Drug Hypersensitivity؛ Drug-Related Side Effects and Adverse Reactions؛ Europe؛ Ferric Compounds؛ Humans؛ Isomaltose؛ Maltose